Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
Key Details
- 1VIS-Fbs only emit fluorescence when bound to their target, reducing background by up to 100-fold.
- 2The technology allows tracking of multiple cellular targets simultaneously across the visible spectrum.
- 3Validated in various mammalian cells, neurons, astrocytes in mice, and zebrafish models.
- 4Certain VIS-Fbs are photo-switchable, supporting high spatial and temporal imaging precision.
- 5Published in Nature Methods; supported by multiple major biomedical funding bodies.
Why It Matters
VIS-Fb probes offer a major advance for live-cell and tissue imaging accuracy, enabling real-time, high-contrast visualization of molecular processes in complex biological systems. This innovation could improve fundamental research and precision imaging applications, including those relevant to disease modeling and radiology AI integration.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.